Impaired renal growth hormone JAK/STAT5 signaling in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 29, Issue 4, 2014, Pages 791-799

  Wiezel, Debbie ^a   Assadi, Mohammed Hani ^a   Landau, Daniel ^a,b   Troib, Ariel ^a   Kachko, Leonid ^a,b   Rabkin, Ralph ^c,d   Segev, Yael ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

chronic kidney disease; growth hormone; IL 6; SOCS3; STAT5

Indexed keywords

GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; INTERLEUKIN 6; JANUS KINASE; MESSENGER RNA; SODIUM CHLORIDE; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; GROWTH RETARDATION; HORMONE RESISTANCE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; MALE; NEPHRECTOMY; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; WEIGHT REDUCTION;

CHRONIC KIDNEY DISEASE; GROWTH HORMONE; IL-6; SOCS3; STAT5;

ADOLESCENT; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMAN GROWTH HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENOUS; INTERLEUKIN-6; JANUS KINASE 2; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RENAL INSUFFICIENCY, CHRONIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 84897421915     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu003     Document Type: Article

References (37)

1. Mahesh S, Kaskel F. Growth hormone axis in chronic kidney disease. Pediatr Nephrol 2008; 23: 41-48
2. Seikaly MG, Salhab N, Gipson D et al. Stature in children with chronic kidney disease: Analysis of NAPRTCS database. Pediatr Nephrol 2006; 21: 793-799
3. Mahan JD, Warady BA. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: A consensus statement. Pediatr Nephrol 2006; 21: 917-930
4. Furth SL, Hwang W, Yang C et al. Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol 2002; 17: 450-455
5. Roelfsema V, Clark RG. The growth hormone and insulinlike growth factor axis: Its manipulation for the benefit of growth disorders in renal failure. J Am Soc Nephrol 2001; 12: 1297-1306
6. Fine RN, Kohaut EC, Brown D et al. Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J Pediatr 1994; 124: 374-382
7. Gupta D, Gardner M, Whaley-Connell A. Role of growth hormone deficiency and treatment in chronic kidney disease. Cardiorenal Med 2011; 1: 174-182
8. Doi T, Striker LJ, Kimata K et al. Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med 1991; 173: 1287-1290
9. Campbell G. Growth-hormone signal transduction. J Pediatr 1997; 131: S42-S44
10. Starr R, Hilton D. SOCS: Suppressors of cytokine signaling. Int J Biochem Cell Biol 1998; 30: 1081-1085
11. Li Y, de Haar C, Chen M et al. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut 2010; 59: 227-235
12. Schaefer F, Chen Y, Tsao T et al. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 2001; 108: 467-475
13. Sun DF, Zheng Z, Tummala P et al. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle. J Am Soc Nephrol 2004; 15: 2630-2636
14. Zheng Z, Sun DF, Tummala P et al. Cardiac resistance to growth hormone in uremia. Kidney Int 2005; 67: 858-866
15. Landau D, Domene H, Flyvbjerg A et al. Differential expression of renal growth hormone receptor and its binding protein in experimental diabetes mellitus. Growth Horm IGF Res 1998; 8: 39-45
16. Fleck C, Appenroth D, Jonas P et al. Suitability of 5/6 nephrectomy (5/6NX) for the induction of interstitial renal fibrosis in rats-Influence of sex, strain, and surgical procedure. Exp Toxicol Pathol 2006; 57: 195-205
17. Pagtalunan ME, Drachman JA, Meyer TW. Methods for estimating the volume of individual glomeruli. Kidney Int 2000; 57: 2644-2649
18. Landau D, Eshet R, Troib A. et al. Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation. Endocrine 2009; 36: 126-134
19. Troib A, Landau D, Kachko L et al. Epiphyseal growth plate growth hormone receptor signaling is decreased in chronic kidney disease related growth retardation. Kidney Int 2013; 84: 940-949
20. Barclay JL, Anderson ST, Waters MJ et al. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells. Mol Endocrinol 2007; 21: 2503-2515
21. Hirschberg R, Adler S. Insulin-like growth factor system and the kidney: Physiology, pathophysiology, and therapeutic implications. Am J Kidney Dis 1998; 31: 901-919
22. Doi T, Striker LJ, Gibson CC et al. Glomerular lesions in mice transgenic for growth hormone and insulin like growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol 1990; 137: 541-552
23. Hazel SJ, Gillespie CM, Moore RJ et al. Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. Kidney Int 1994; 46: 58-68
24. Santos F, Chan JC, Hanna JD et al. The effect of growth hormone on the growth failure of chronic renal failure. Pediatr Nephrol 1992; 6: 262-266
25. Müller-Wiefel D, Frisch H, Tulassay T et al. Treatment of growth failure with growth hormone in children with chronic kidney disease: An openlabel long-Term study. Clin Nephrol 2010; 74: 97-105
26. Wormald S, Hilton DJ. Inhibitors of cytokine signal transduction. J Biol Chem 2004; 279: 821-824
27. Metcalf D, Greenhalgh CJ, Viney E et al. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 2000; 405: 1069-1073
28. Reiser K, Summers P, Medrano JF et al. Effects of elevated circulating IGF-1 on the extracellular matrix in 'high-growth' C57BL/6J mice. Am J Physiol 1996; 271: R696-R703
29. Landau D, Israel E, Rivkis I et al. The effect of growth hormone on the development of diabetic kidney disease in rats. Nephrol Dial Transplant 2003; 18: 694-702
30. Lang CH, Frost RA. Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection. Curr Opin Clin Nutr Metab Care 2002; 5: 271-279
31. Von Laue S, Ross RJ. Inflammatory cytokines and acquired growth hormone resistance. Growth Horm IGF Res 2000; 10: S9-S14
32. Chuang PY, He JC. JAK/STAT signaling in renal diseases. Kidney Int 2010; 78: 231-234
33. Pang M, Ma L, Gong R et al. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int 2010; 78: 257-268
34. Jones SA, Horiuchi S, Topley N et al. The soluble interleukin 6 receptor: Mechanisms of production and implications in disease. FASEB J 2001; 15: 43-58
35. Pecoits-Filho R, Barany P, Lindholm B et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002; 17: 1684-1688
36. Carrero JJ, Stenvinkel P. Inflammation in end-stage renal disease-what have we learned in 10 years? Semin Dial 2010; 23: 498-509
37. Pecoits-Filho R, Heimbürger O, Bárány P et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003; 41: 1212-1218